You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Roche post mixed results for etrolizumab in ulcerative colitis

Roche’s investigational medicine etrolizumab has demonstrated mixed results in phase III studies in patients with moderately to severely active ulcerative colitis.